Comparison of Second-line Hepatic Arterial Infusion Chemotherapy and Tyrosine Kinase Inhibitors in Advanced Hepatocellular Carcinoma. Yoo JS, Tak KY, Cho HS, Han JW, et al. Radiology 2026;320:e253280.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yoo JS, Tak KY, Cho HS, Han JW, et al. Comparison of Second-line Hepatic Arterial Infusion Chemotherapy and Tyrosine Kinase Inhibitors in Advanced Hepatocellular Carcinoma. Radiology 2026;320:e253280.
PMID: 42550027